Showing results (871-880 of 889) with videos related to

Sort By:
Pageof 89
Frontiers in Immunology|November 29, 2023
Corrigendum: Vaccination with immune complexes modulates the elicitation of functional antibodies against HIV-1Catarina E Hioe, Xiaomei Liu, Andrew N Banin, et al.
American Journal of Clinical Oncology|July 20, 2012
ACR Appropriateness Criteria® definitive therapy for early-stage cervical cancerWilliam Small, Jonathan B Strauss, Anuja Jhingran, et al.
International Journal of Radiation Oncology, Biology, Physics|May 15, 2002
An Internet-ready database for prospective randomized clinical trials of high-dose-rate brachytherapy for adenocarcinoma of the prostatePhillip M Devlin, Christina R Brus, Julia Kazakin, et al.
Antimicrobial Agents and Chemotherapy|September 20, 2022
A Systems-Based Analysis of Mono- and Combination Therapy for Carbapenem-Resistant Klebsiella pneumoniae Bloodstream InfectionsCourtney L Luterbach, Hongqiang Qiu, Patrick O Hanafin, et al.
Chemical Science|August 18, 2025
Double crossed? Structural and computational studies of an unusually crosslinked haem in <i>Methylococcus capsulatus</i> cytochrome P460Hans E Pfalzgraf, Aditya G Rao, Kakali Sen, et al.
Cancers|February 15, 2022
Microtentacle Formation in Ovarian CarcinomaJocelyn C Reader, Cong Fan, Eleanor Claire-Higgins Ory, et al.
British Journal of Cancer|February 12, 2022
Randomised phase II trial of weekly ixabepilone ± biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancerDana M Roque, Eric R Siegel, Natalia Buza, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 22, 2023
A population pharmacokinetic model of polymyxin B based on prospective clinical data to inform dosing in hospitalized patientsPatrick O Hanafin, Andrea Kwa, Alexandre P Zavascki, et al.
Clinical Pharmacology and Therapeutics|June 17, 2025
Population Pharmacokinetic/Toxicodynamic Model for Polymyxin B in Critically Ill Patients to Identify the Risk of NephrotoxicityPatrick O Hanafin, Ramya Mahadevan, Gauri G Rao, et al.
Annals of Pediatric Cardiology|October 20, 2021
Outcome of COVID-19-positive children with heart disease and grown-ups with congenital heart disease: A multicentric study from IndiaSakshi Sachdeva, Sivasubramanian Ramakrishnan, Mrigank Choubey, et al.
Pageof 89